glp 1 agonists with cardiovascular benefit benefits of glucagon-like peptide-1 receptor SGLTi and GLP-1 in HF
Description
doi: 10.1210/en.2014-1675
Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity (STEP 5)
One of the key areas of interest for researchers will be to study how GLP-1 agonists might enhance recovery and outcomes for people who have had joint replacement surgery
This evaluation considered random sequence generation, allocation concealment, blinding of participants and personnel, incomplete outcome data and selective reporting
H., Bays H
We saw widespread shortages with Wegovy and Zepbound
